标题
Aβ-oligomers: A potential therapeutic target for Alzheimer's disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 239, Issue -, Pages 124231
出版商
Elsevier BV
发表日期
2023-03-29
DOI
10.1016/j.ijbiomac.2023.124231
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-amyloid antibody therapies in Alzheimer's disease
- (2023) Robert Perneczky et al. BRAIN
- NIH Pilots Telehealth Program for COVID-19
- (2023) Howard D. Larkin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aza-Residue Modulation of Cyclic d,l-α-Peptide Nanotube Assembly with Enhanced Anti-Amyloidogenic Activity
- (2023) Maram Habashi et al. Journal of Medicinal Chemistry
- How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β1−40
- (2023) Benedikt Schwarze et al. MACROMOLECULAR BIOSCIENCE
- Identification of β‐aminopyrrolidine containing peptides as β‐amyloid aggregation inhibitors for Alzheimer's disease
- (2022) Habbanakuppe D. Preetham et al. JOURNAL OF PEPTIDE SCIENCE
- Taylor Dispersion Analysis and Atomic Force Microscopy Provide a Quantitative Insight into the Aggregation Kinetics of Aβ (1–40)/Aβ (1–42) Amyloid Peptide Mixtures
- (2022) Mihai Deleanu et al. ACS Chemical Neuroscience
- Cross-Seeding Controls Aβ Fibril Populations and Resulting Functions
- (2022) Michael J. Lucas et al. JOURNAL OF PHYSICAL CHEMISTRY B
- The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease
- (2022) Stefano Musardo et al. MOLECULAR THERAPY
- Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
- (2022) Mingchao Shi et al. Frontiers in Aging Neuroscience
- Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
- (2022) Charles G. Withington et al. Frontiers in Neurology
- Ganglioside Nanocluster-Targeting Peptidyl Inhibitor Prevents Amyloid β Fibril Formation on the Neuronal Membrane
- (2022) Teruhiko Matsubara et al. ACS Chemical Neuroscience
- Functionally linked potassium channel activity in cerebral endothelial and smooth muscle cells is compromised in Alzheimer’s disease
- (2022) Jade L. Taylor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoscale Characterization of Parallel and Antiparallel β-Sheet Amyloid Beta 1–42 Aggregates
- (2022) Kiryl Zhaliazka et al. ACS Chemical Neuroscience
- Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation
- (2022) Krushna Sonar et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Effects of pramipexole on beta-amyloid1–42 memory deficits and evaluation of oxidative stress and mitochondrial function markers in the hippocampus of Wistar rat
- (2022) Mohd. Salman et al. NEUROTOXICOLOGY
- Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
- (2022) Narjes Baazaoui et al. Biomolecules
- Multiple Actions of H2S-Releasing Peptides in Human β-Amyloid Expressing C. elegans
- (2022) Rafat Ali et al. ACS Chemical Neuroscience
- Atrial Natriuretic Peptide Associated with Cardiovascular Diseases Inhibits Amyloid-β Aggregation via Cross-Seeding
- (2022) Yijing Tang et al. ACS Chemical Neuroscience
- Early diagnosis and treatment of Alzheimer’s disease by targeting toxic soluble Aβ oligomers
- (2022) Maram Habashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Real-Time Validation of the Effectiveness of Third-Generation Hyperbranched Poly(ɛ-lysine) Dendrons-Modified KLVFF Sequences to Bind Amyloid-β1-42 Peptides Using an Optical Waveguide Light-Mode Spectroscopy System
- (2022) Valeria Perugini et al. SENSORS
- Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
- (2022) Meenakshi Bose et al. Cells
- Adult hippocampal neurogenesis in aging and Alzheimer's disease
- (2021) Kelsey R. Babcock et al. Stem Cell Reports
- Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease
- (2021) Gai Ayalon et al. Science Translational Medicine
- Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates
- (2021) A. Duro-Castano et al. Science Advances
- The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA
- (2021) Jason Karlawish et al. Nature Reviews Neurology
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
- (2021) Stephen Salloway et al. JAMA Neurology
- Combating amyloid-induced cellular toxicity and stiffness by designer peptidomimetics
- (2021) Mouli Konar et al. RSC Chemical Biology
- Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
- (2020) Seyyed Abolghasem Ghadami et al. BIOMACROMOLECULES
- Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
- (2020) Thomas C. T. Michaels et al. Nature Chemistry
- Ultrastructural evidence for self-replication of Alzheimer-associated Aβ42 amyloid along the sides of fibrils
- (2020) Mattias Törnquist et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complete aggregation pathway of amyloid β (1-40) and (1-42) resolved on an atomically clean interface
- (2020) Peter Niraj Nirmalraj et al. Science Advances
- Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
- (2020) Patrick Flagmeier et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
- (2020) Francesco A. Aprile et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage
- (2020) Sonia Ciudad et al. Nature Communications
- Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer’s disease
- (2020) Seung-Jun Yoo et al. Scientific Reports
- Time-Dependent Lipid Dynamics, Organization and Peptide-Lipid Interaction in Phospholipid Bilayers with Incorporated β-Amyloid Oligomers
- (2020) Wei Qiang et al. Journal of Physical Chemistry Letters
- Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
- (2020) Thomas C. T. Michaels et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The amyloid cascade and Alzheimer’s disease therapeutics: theory versus observation
- (2019) Rudy J. Castellani et al. LABORATORY INVESTIGATION
- MnCO3 as a New Electrochemiluminescence Emitter for Ultrasensitive Bioanalysis of β-Amyloid1–42 Oligomers Based on Site-Directed Immobilization of Antibody
- (2019) Yue Jia et al. ACS Applied Materials & Interfaces
- Amyloid-β Peptide-Lipid Bilayer Interaction investigated by Supercritical Angle Fluorescence
- (2019) Valentin Dubois et al. ACS Chemical Neuroscience
- α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer’s disease
- (2019) Dylan Shea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
- (2019) Tom Scheidt et al. Science Advances
- Optimal control strategies for inhibition of protein aggregation
- (2019) Thomas C. T. Michaels et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
- (2019) Ebrima Gibbs et al. Scientific Reports
- Aggregation States of Aβ1–40, Aβ1–42 and Aβp3–42 Amyloid Beta Peptides: A SANS Study
- (2019) Giulia Festa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Observation of β-Amyloid Peptide Oligomerization by Pressure-Jump NMR Spectroscopy
- (2019) C. Ashley Barnes et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Fibrillar and Nonfibrillar Amyloid Beta Structures Drive Two Modes of Membrane-Mediated Toxicity
- (2019) Crystal M. Vander Zanden et al. LANGMUIR
- Secondary nucleation in amyloid formation
- (2018) Mattias Törnquist et al. CHEMICAL COMMUNICATIONS
- The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
- (2018) Erika N. Cline et al. JOURNAL OF ALZHEIMERS DISEASE
- On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
- (2018) Xiaoting Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genesis of Neuroprotective Peptoid from Aβ30–34 Inhibits Aβ Aggregation and AChE Activity
- (2018) Krishnangsu Pradhan et al. ACS Chemical Neuroscience
- β-Alanyl-L-Histidine Rescues Cognitive Deficits Caused by Feeding a High Fat Diet in a Transgenic Mouse Model of Alzheimer's Disease
- (2018) Bruno Herculano et al. JOURNAL OF ALZHEIMERS DISEASE
- Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
- (2018) Claudio Soto et al. NATURE NEUROSCIENCE
- Dynamic micellar oligomers of amyloid beta peptides play a crucial role in their aggregation mechanisms
- (2018) Bertrand Morel et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- SAR by kinetics for drug discovery in protein misfolding diseases
- (2018) Sean Chia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in developing novel therapeutic strategies for Alzheimer’s disease
- (2018) Jiqing Cao et al. Molecular Neurodegeneration
- Pathways of Amyloid-β Aggregation Depend on Oligomer Shape
- (2017) Bogdan Barz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
- (2017) Anna Munke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates
- (2017) Sean Chia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
- (2017) Fatou Amar et al. Science Signaling
- Pyroglutamate-modified Aβ(3-42) affects aggregation kinetics of Aβ(1-42) by accelerating primary and secondary pathways
- (2017) C. Dammers et al. Chemical Science
- The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
- (2017) Fatou Amar et al. Science Signaling
- Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
- (2017) Francesco A. Aprile et al. Science Advances
- Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: ACC-001 Clinical Trials Are Ongoing
- (2017) J. Michael Ryan et al. JOURNAL OF ALZHEIMERS DISEASE
- LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity
- (2017) Ivica Granic et al. JOURNAL OF ALZHEIMERS DISEASE
- Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP)
- (2016) Thomas L. Williams et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Designed Glycopeptidomimetics Disrupt Protein–Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability
- (2016) Julia Kaffy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amyloid β-Protein Assembly and Alzheimer’s Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation
- (2016) Nicholas J. Economou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- High-speed atomic force microscopy reveals structural dynamics of amyloid β1–42aggregates
- (2016) Takahiro Watanabe-Nakayama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
- (2016) Paolo Arosio et al. Nature Communications
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Fabrication of an antibody-aptamer sandwich assay for electrochemical evaluation of levels of β-amyloid oligomers
- (2016) Yanli Zhou et al. Scientific Reports
- (R)-α-trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation
- (2015) Alexandra Botz et al. BIOPOLYMERS
- N-Terminal Extensions Retard Aβ42 Fibril Formation but Allow Cross-Seeding and Coaggregation with Aβ42
- (2015) Olga Szczepankiewicz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
- (2015) Samuel I A Cohen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- On the lag phase in amyloid fibril formation
- (2015) Paolo Arosio et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins
- (2015) Pietro Sormanni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
- (2015) Sergio T. Ferreira et al. Frontiers in Cellular Neuroscience
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
- (2015) Samuel I A Cohen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration
- (2015) Peng Liu et al. Cell Reports
- Rational Design and Identification of a Non-Peptidic Aggregation Inhibitor of Amyloid-β Based on a Pharmacophore Motif Obtained fromcyclo[-Lys-Leu-Val-Phe-Phe-]
- (2014) Tadamasa Arai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Taurine attenuates amyloid β 1–42-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells
- (2014) Qinru Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease
- (2014) Samuel A. Kotler et al. CHEMICAL SOCIETY REVIEWS
- Cyclic Peptides as Inhibitors of Amyloid Fibrillation
- (2014) Jinghui Luo et al. CHEMISTRY-A EUROPEAN JOURNAL
- Computational and Experimental Studies on β-Sheet Breakers Targeting Aβ1–40Fibrils
- (2014) Velia Minicozzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Sensitive A Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
- (2014) M. J. Savage et al. JOURNAL OF NEUROSCIENCE
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
- (2014) Soyon Hong et al. NEURON
- Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides
- (2014) Georg Meisl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based study of antiamyloidogenic cyclic d,l-α-peptides
- (2014) Marina Chemerovski-Glikman et al. TETRAHEDRON
- Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
- (2014) Lars Lannfelt et al. Alzheimers Research & Therapy
- Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers
- (2014) Gene Hopping et al. eLife
- Single Point Mutations Induce a Switch in the Molecular Mechanism of the Aggregation of the Alzheimer’s Disease Associated Aβ42 Peptide
- (2013) Benedetta Bolognesi et al. ACS Chemical Biology
- γ-AApeptide-based small-molecule ligands that inhibit Aβ aggregation
- (2013) Haifan Wu et al. CHEMICAL COMMUNICATIONS
- In Vitro and Mechanistic Studies of an Antiamyloidogenic Self-Assembled Cyclic d,l-α-Peptide Architecture
- (2013) Michal Richman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Proliferation of amyloid- 42 aggregates occurs through a secondary nucleation mechanism
- (2013) S. I. A. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human LilrB2 Is a -Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
- (2013) T. Kim et al. SCIENCE
- On the subject of rigor in the study of amyloid β-protein assembly
- (2013) David B Teplow Alzheimers Research & Therapy
- Synapse-Binding Subpopulations of Aβ Oligomers Sensitive to Peptide Assembly Blockers and scFv Antibodies
- (2012) Pauline T. Velasco et al. ACS Chemical Neuroscience
- The N-Methylated Peptide SEN304 Powerfully Inhibits Aβ(1–42) Toxicity by Perturbing Oligomer Formation
- (2012) Hozefa Amijee et al. BIOCHEMISTRY
- The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
- (2012) I. W. Hamley CHEMICAL REVIEWS
- From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
- (2012) Samuel I.A. Cohen et al. JOURNAL OF MOLECULAR BIOLOGY
- Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans
- (2012) Seema Jagota et al. MEDICINAL CHEMISTRY RESEARCH
- A Survey of Peptides with Effective Therapeutic Potential in Alzheimer’s Disease Rodent Models or in Human Clinical Studies
- (2012) N. Sun et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation
- (2011) Bertrand Dorgeret et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- AFFITOME® technology in neurodegenerative diseases: The doubling advantage
- (2011) Achim Schneeberger et al. Human vaccines & immunotherapeutics
- Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
- (2011) Samuel I. A. Cohen et al. JOURNAL OF CHEMICAL PHYSICS
- Single Molecule Tracking Analysis Reveals That the Surface Mobility of Amyloid Oligomers Is Driven by Their Conformational Structure
- (2011) Martino Calamai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synthesis of a New Class of Bis(thiourea)hydrazide Pseudopeptides as Potential Inhibitors of β-Sheet Aggregation
- (2011) Jan J. Klein et al. ORGANIC LETTERS
- Structure-based design of conformation- and sequence-specific antibodies against amyloid
- (2011) J. M. Perchiacca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oral Treatment with the d-Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer’s Disease Transgenic Mice
- (2010) Susanne Aileen Funke et al. ACS Chemical Neuroscience
- Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of β-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer’s Disease
- (2010) Mark Taylor et al. BIOCHEMISTRY
- Aβ polymerization through interaction with membrane gangliosides
- (2010) Katsumi Matsuzaki et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape
- (2010) Yifat Miller et al. CHEMICAL REVIEWS
- Mitochondrial medicine for neurodegenerative diseases
- (2010) Heng Du et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Specificity and sensitivity of the Abeta oligomer ELISA
- (2010) Andrea C. Klaver et al. JOURNAL OF NEUROSCIENCE METHODS
- Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease
- (2010) Balpreet Matharu et al. PEPTIDES
- Rationally designed dehydroalanine (ΔAla)-containing peptides inhibit amyloid-β (Aβ) peptide aggregation
- (2009) Vijayaraghavan Rangachari et al. BIOPOLYMERS
- Amino Acid Position-specific Contributions to Amyloid β-Protein Oligomerization
- (2009) Samir K. Maji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease
- (2009) Summer L. Bernstein et al. Nature Chemistry
- Transport of Alzheimer Disease Amyloid-β-Binding d-Amino Acid Peptides across an In Vitro Blood–Brain Barrier Model
- (2009) Hongmei Liu et al. REJUVENATION RESEARCH
- An Analytical Solution to the Kinetics of Breakable Filament Assembly
- (2009) T. P. J. Knowles et al. SCIENCE
- Active and Passive Immunotherapy for Neurodegenerative Disorders
- (2008) David L. Brody et al. Annual Review of Neuroscience
- Designing Peptide Inhibitors for Oligomerization and Toxicity of Alzheimer's β-Amyloid Peptide†
- (2008) Brian M. Austen et al. BIOCHEMISTRY
- Reduction of Alzheimer’s Disease Amyloid Plaque Load in Transgenic Mice by D3, a D-Enantiomeric Peptide Identified by Mirror Image Phage Display
- (2008) Thomas van Groen et al. ChemMedChem
- In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42-Binding D-Enantiomeric Peptides in Transgenic AD Mouse Models
- (2008) Thomas van Groen et al. ChemMedChem
- Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17–21 β-amyloid sequence
- (2008) Cesare Giordano et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates
- (2008) Zoë van Helmond et al. JOURNAL OF NEUROSCIENCE METHODS
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started